Cullinan Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.About CGEM
Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617.
CGEM Key Statistics
Stock Snapshot
The current Cullinan Therapeutics(CGEM) stock price is $18.13, with a market capitalization of 1.12B. The stock trades at a price-to-earnings (P/E) ratio of -4.88.
During the trading session on 2026-07-11, Cullinan Therapeutics(CGEM) shares reached a daily high of $18.33 and a low of $17.27. At a current price of $18.13, the stock is +5.0% higher than the low and still -1.1% under the high.
Trading volume for Cullinan Therapeutics(CGEM) stock has reached 630.03K, versus its average volume of 940.29K.
The stock's 52-week range extends from a low of $5.68 to a high of $19.43.
The stock's 52-week range extends from a low of $5.68 to a high of $19.43.
Analyst ratings
100%
of 13 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.